Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV003244334 | SCV003940934 | uncertain significance | Inborn genetic diseases | 2023-06-02 | criteria provided, single submitter | clinical testing | The c.1711G>A (p.E571K) alteration is located in exon 8 (coding exon 8) of the PKD1 gene. This alteration results from a G to A substitution at nucleotide position 1711, causing the glutamic acid (E) at amino acid position 571 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |